Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Mirum Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 11
Estimación de BPA
$-0.283
Estimación de ingresos trimestrales
$112.67M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$429.16M
Analice el historial de beneficios de Mirum Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
MIRM | Mirum Pharmaceuticals | -$0.30 | -$0.28 | — | — | $90.38M | $112.67M | — | — | 11/11/2025 | |
MIRM | Mirum Pharmaceuticals | -$0.52 | -$0.33 | -$0.12 | 62.50% | $77.88M | $107.91M | $127.78M | 18.08% | 08/06/2025 | |
MIRM | Mirum Pharmaceuticals | -$0.54 | -$0.33 | -$0.30 | -11.11% | $69.22M | $98.40M | $111.60M | 13.41% | 05/07/2025 | |
MIRM | Mirum Pharmaceuticals | -$0.66 | -$0.24 | -$0.49 | -96.00% | $69.55M | $96.61M | $99.41M | 2.87% | 02/26/2025 | |
MIRM | Mirum Pharmaceuticals | -$0.57 | -$0.45 | -$0.30 | 33.33% | $47.73M | $82.02M | $90.38M | 10.20% | 11/12/2024 | |
MIRM | Mirum Pharmaceuticals | -$1.94 | -$0.47 | -$0.52 | -10.64% | $37.50M | $75.25M | $77.88M | 3.49% | 08/07/2024 | |
MIRM | Mirum Pharmaceuticals | -$0.80 | -$0.48 | -$0.54 | -12.50% | $31.60M | $70.17M | $69.22M | -1.35% | 05/08/2024 | |
MIRM | Mirum Pharmaceuticals | -$0.99 | -$0.24 | -$0.66 | -175.00% | $27.91M | $67.76M | $69.55M | 2.65% | 02/28/2024 | |
MIRM | Mirum Pharmaceuticals | -$1.02 | -$0.65 | -$0.57 | 12.31% | $18.78M | $37.12M | $47.73M | 28.57% | 11/02/2023 | |
MIRM | Mirum Pharmaceuticals | -$0.84 | -$0.81 | -$1.94 | -139.51% | $17.48M | $30.00M | $37.50M | 24.99% | 08/03/2023 | |
MIRM | Mirum Pharmaceuticals | -$1.17 | -$0.94 | -$0.80 | 14.89% | $12.89M | $28.69M | $31.60M | 10.14% | 05/04/2023 | |
MIRM | Mirum Pharmaceuticals | -$1.65 | -$1.02 | -$0.99 | 2.94% | $3.14M | $24.57M | $27.91M | 13.58% | 03/08/2023 | |
MIRM | Mirum Pharmaceuticals | -$1.55 | -$1.07 | -$1.02 | 4.67% | $5.00M | $20.81M | $18.78M | -9.75% | 11/09/2022 | |
MIRM | Mirum Pharmaceuticals | -$1.45 | -$1.15 | -$0.84 | 26.96% | $11.00M | $15.42M | $17.48M | 13.39% | 08/04/2022 | |
MIRM | Mirum Pharmaceuticals | $1.68 | -$1.34 | -$1.17 | 12.69% | $0.00 | $8.46M | $12.89M | 52.39% | 05/05/2022 | |
MIRM | Mirum Pharmaceuticals | -$1.43 | $0.34 | -$1.65 | -585.29% | $0.00 | $62.65M | $3.14M | -94.99% | 03/09/2022 | |
MIRM | Mirum Pharmaceuticals | -$0.86 | -$1.73 | -$1.55 | 10.40% | $0.00 | $830.00K | $5.00M | 502.41% | 11/15/2021 | |
MIRM | Mirum Pharmaceuticals | -$0.93 | — | -$1.45 | — | $0.00 | $14.50M | $11.00M | -24.14% | 08/05/2021 | |
MIRM | Mirum Pharmaceuticals | -$0.86 | -$0.69 | $1.68 | 343.48% | $0.00 | $8.33M | $0.00 | -100.00% | 05/06/2021 | |
MIRM | Mirum Pharmaceuticals | -$0.79 | — | -$1.43 | — | $0.00 | — | $0.00 | — | 03/09/2021 | |
MIRM | Mirum Pharmaceuticals | -$0.84 | — | -$0.86 | — | $0.00 | — | $0.00 | — | 11/12/2020 |
Mirum Pharmaceuticals (MIRM) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $-0.12 | $-0.33 | 62.5 % |
| Q1 | 2025-05-07 | $-0.30 | $-0.33 | -11.1 % |
| Q4 | 2025-02-26 | $-0.49 | $-0.24 | -96.0 % |
| Q3 | 2024-11-12 | $-0.30 | $-0.45 | 33.3 % |
Mirum Pharmaceuticals (MIRM) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $127.79M | $107.91M | 18.1 % |
| Q1 | 2025-05-07 | $111.60M | $98.40M | 13.4 % |
| Q4 | 2025-02-26 | $99.41M | $96.61M | 2.87 % |
| Q3 | 2024-11-12 | $90.38M | $82.02M | 10.2 % |
PREGUNTAS FRECUENTES
¿Cuándo Mirum Pharmaceuticals (NASDAQ:MIRM) publicará los resultados?
Está previsto que Mirum Pharmaceuticals (MIRM) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 6, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Mirum Pharmaceuticals (NASDAQ:MIRM)?
El BPA real fue de $-0.12, que superó la estimación de $-0.33.
¿Cuáles fueron los ingresos de Mirum Pharmaceuticals (NASDAQ:MIRM)?
Los ingresos reales fueron $127.8M, que superó la estimación de $107.9M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.